Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0220723 (
PCA
)
4,687
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The spectrum of low molecular weight compounds, in particular of ribonucleotides, within first cleavage stage embryos of the polar lobe-forming mollusc Nassarius reticulatus and the distribution of the compounds within the embryo at the trefoil stage of first cleavage are analysed by means of capillary isotachophoresis after 0.5 M
PCA
extraction. The compounds which are found in the whole trefoil embryo (T), the lobeless part (LL), and the polar lobe (PL) respectively, and the mean quantities (nmol. microliter-1; n = 6) are: UTP (11.5, 4.8, 5.6), ITP (8.5, 3.6, 5.0), GTP (10.3, 3.0, 9.0), ATP (29.8, 13.4, 18.8), UDP (11.8, 3.4, 8.7),
CTP
(8.0, 3.1, 4.5), GDP (5.3, 2.6, 3.4), ADP (16.5, 6.1, 11.6), CDP (4.0, 1.4, 2.6), GMP (4.7, 2.7, 4.3), glucose-6-phosphate (G6P) (53.5, 38.8, 13.0). These compounds appear to be localized in the non-yolk cytoplasmic pool. As the volume ratio of PL/LL for total volume and for non-yolk cytoplasmic volume is about 0.74 and 0.60 respectively, the concentration of all nucleotides in PL as compared to LL is significantly higher (HO, p less than 0.001), both relative to the total volume and to the non-yolk cytoplasmic volume. The G6P concentration is considerably higher in the lobeless part. The morphogenetic role of the vegetal pole compartment of the egg apparently is correlated with a relatively high level of its nucleotide contents.
...
PMID:Composition of the nucleotides pool in a morphogenetic compartment in eggs of Nassarius reticulatus (Mollusca) analysed by capillary isotachophoresis. 406 27
Piceatannol (3,3',4,5'-tetrahydroxy-trans-stilbene;
PCA
) is a naturally occurring metabolite of resveratrol (3,4',5-trihydroxy-trans-stilbene; RV). In this study, we identified additional biochemical targets of
PCA
in human HL-60 promyelocytic leukemia cells. Incubation with
PCA
led to a significant proportion of apoptotic cells and caused an arrest in the G2-M phase of the cell cycle.
PCA
depleted intracellular dCTP and dGTP pools, and inhibited the incorporation of 14C-labeled cytidine into DNA.
PCA
significantly abolished all NTP pools, and sequential treatment with
PCA
and Ara-C yielded synergistic growth inhibitory effects because of remarkably increased Ara-
CTP
formation after
PCA
preincubation. Due to these promising results,
PCA
may support conventional chemotherapy of human malignancies and therefore, deserves further preclinical and in vivo testing.
...
PMID:Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C. 1881 4